Insiders who reported open-market trades in the last 12 months at the companies Peter E. Boyd files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Daniel Barber - $1.22M in AQST purchases and sales in the last 12 months
A. Ernest Toth Jr. - $243K in AQST purchases and sales in the last 12 months
Cassie Jung - $191K in AQST purchases and sales in the last 12 months
Lori J. Braender - $167K in AQST purchases and sales in the last 12 months
Julie Krop - $125K in AQST purchases and sales in the last 12 months
Sherry Korczynski - $111K in AQST purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Peter E. Boyd is a corporate insider, tracked as Chief People Officer of Aquestive Therapeutics, Inc. (AQST). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Peter E. Boyd submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Peter E. Boyd been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($337K) across all tracked filings.
Peter E. Boyd is Chief People Officer of Aquestive Therapeutics, Inc. (AQST). 8 SEC Form 4 filings on record going back to 2025, most recently on 10 September 2026. Most recent open-market trade: sold $124K of AQST on 11 March 2026. Lifetime open-market sales: $337K.
Recent transactions
8
The latest 8 SEC Form 4 transactions reported by Peter E. Boyd.
InsiderAlpha's records for Peter E. Boyd go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. 1 recorded transaction carries a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
